SANOFI (1SAN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1SAN - FR0000120578 - Common Stock
83.25 EUR
-1.39 (-1.64%)
Taking everything into account, 1SAN scores 6 out of 10 in our fundamental rating. 1SAN was compared to 54 industry peers in the Pharmaceuticals industry. While 1SAN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1SAN has a correct valuation and a medium growth rate. Finally 1SAN also has an excellent dividend rating. These ratings would make 1SAN suitable for dividend investing!
1. Profitability
1.1 Basic Checks
In the past year 1SAN was profitable.
1SAN had a positive operating cash flow in the past year.
Each year in the past 5 years 1SAN has been profitable.
1SAN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1SAN's Return On Assets of 11.05% is fine compared to the rest of the industry. 1SAN outperforms 79.63% of its industry peers.
With a decent Return On Equity value of 19.73%, 1SAN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
1SAN's Return On Invested Capital of 13.84% is fine compared to the rest of the industry. 1SAN outperforms 70.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1SAN is significantly below the industry average of 13.89%.
The last Return On Invested Capital (13.84%) for 1SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
Looking at the Profit Margin, with a value of 20.35%, 1SAN belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
1SAN's Operating Margin of 23.59% is fine compared to the rest of the industry. 1SAN outperforms 61.11% of its industry peers.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN has a Gross Margin of 71.70%. This is comparable to the rest of the industry: 1SAN outperforms 55.56% of its industry peers.
1SAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1SAN is creating value.
The number of shares outstanding for 1SAN remains at a similar level compared to 1 year ago.
The number of shares outstanding for 1SAN remains at a similar level compared to 5 years ago.
1SAN has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.21, 1SAN belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that 1SAN is not too dependend on debt financing.
1SAN's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. 1SAN outperforms 75.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.63%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1SAN should not have too much problems paying its short term obligations.
1SAN's Current ratio of 1.27 is in line compared to the rest of the industry. 1SAN outperforms 40.74% of its industry peers.
A Quick Ratio of 0.94 indicates that 1SAN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, 1SAN is in line with its industry, outperforming 46.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for 1SAN have decreased by -5.35% in the last year.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 2.56% in the past year.
1SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
1SAN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.11% yearly.
1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.55% yearly.
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.95 indicates a reasonable valuation of 1SAN.
85.19% of the companies in the same industry are more expensive than 1SAN, based on the Price/Earnings ratio.
1SAN is valuated cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.69 indicates a reasonable valuation of 1SAN.
85.19% of the companies in the same industry are more expensive than 1SAN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.56. 1SAN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.95 | ||
| Fwd PE | 9.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1SAN is valued a bit cheaper than 61.11% of the companies in the same industry.
1SAN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1SAN is cheaper than 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.08 | ||
| EV/EBITDA | 10.67 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.63
PEG (5Y)2.15
EPS Next 2Y5.77%
EPS Next 3Y5.98%
5. Dividend
5.1 Amount
1SAN has a Yearly Dividend Yield of 4.64%, which is a nice return.
Compared to an average industry Dividend Yield of 2.90, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, 1SAN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.64% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
34.82% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
BIT:1SAN (12/8/2025, 7:00:00 PM)
83.25
-1.39 (-1.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners46.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap202.21B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target107.64 (29.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.64% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)0.89%
PT rev (3m)-1.61%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.95 | ||
| Fwd PE | 9.69 | ||
| P/S | 2.98 | ||
| P/FCF | 20.08 | ||
| P/OCF | 17.77 | ||
| P/B | 2.89 | ||
| P/tB | 21.76 | ||
| EV/EBITDA | 10.67 |
EPS(TTM)7.6
EY9.13%
EPS(NY)8.59
Fwd EY10.32%
FCF(TTM)4.15
FCFY4.98%
OCF(TTM)4.69
OCFY5.63%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)3.63
PEG (5Y)2.15
Graham Number70.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.63%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.46%
EBIT Next 3Y13.42%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / 1SAN.MI FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to 1SAN.MI.
What is the valuation status for 1SAN stock?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (1SAN.MI) has a profitability rating of 7 / 10.
How financially healthy is SANOFI?
The financial health rating of SANOFI (1SAN.MI) is 5 / 10.
What is the earnings growth outlook for SANOFI?
The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 3.02% in the next year.